hotspot -WSS

hotspot

author：hotspot 2025-09-30 00:49:46 - browse：89816

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

knowledge

focus

WSS

A new drug could help frostbite victims avoid its ravages

Maui wildfire now ranks as the fifth

YouTube cracks down on misinformation on cancer treatment

New study raises questions about niacin and heart health

Hospitals are dialing back on venture capital investing

A new drug could help frostbite victims avoid its ravages

focus

hotspot

entertainment

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What to know about the judge who will handle the Trump case

Drug repurposing or repositioning? The language matters

Montana youths win climate lawsuit against state for promoting fossil fuels

How to save PrEP access — and even expand it

Researchers tackle phage therapy hurdles for wider adoption

At least 13 dead in Texas as scorching temps continue

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

focus

Researchers tackle phage therapy hurdles for wider adoption

Biden administration begins canceling student loan debt for 804,000 borrowers

Novo Nordisk touts Wegovy study, but still struggling with supply

WATCH: Why do our ears pop?

New study raises questions about niacin and heart health

Congress may force more Covid

Wikipedia

knowledge

focus

entertainment